MYLAN 233 (Efavirenz 600 mg)
Pill with imprint MYLAN 233 is Yellow, Capsule-shape and has been identified as Efavirenz 600 mg. It is supplied by Mylan Pharmaceuticals Inc..
Efavirenz is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 233
Efavirenz
- Imprint
- MYLAN 233
- Strength
- 600 mg
- Color
- Yellow
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2233
- Inactive Ingredients
-
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.
More about efavirenz
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 7 Reviews
- Drug class: NNRTIs
Consumer resources
Other brands: Sustiva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
